Centene (CNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Centene Corp has dropped over 40%, and Adhishthana principles suggest that the decline signals deeper structural issues.

Centene is set to announce its second-quarter results later this month, and analysts anticipate double-digit earnings drop.

U.S. equities mostly gained at midday on a new U.S.-Vietnam trade agreement, although the advance was limited by a decline in ...

CNBC’s Jim Cramer gave his take Centene and the broader health insurance space after shares plummeted on Wednesday.

A class action securities lawsuit was filed against Centene Corporation that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between December 12, 2024 ...

The Clayton-based health giant is likely to face increased challenges as federal government tightens Medicaid eligibility and ...

Shares of Centene are experiencing a historic collapse this week. Wednesday marked the worst single-day performance in the company's history.

The significant downgrade comes as UBS revised its earnings per share estimates for Centene, projecting a 55% decline to $3.25 for 2025 and a 45% decline to $4.50 for 2026.

CNBC's Jim Cramer offered his take on Centene and the broader health insurance space as its stock plummeted when management unexpectedly withdrew full-year guidance.

On this news, Centene's stock price fell $22.87, or 40.4%, to close at $33.78 per share on July 2, 2025, thereby injuring invetors. What Is The Lawsuit About?